High-contrast imaging with Keck adaptive optics and OSIRIS
Michael W. McElwain(Goddard Space Flight Center), B. Zuckerman(University of California, Los Angeles), Stanimir Metchev(California Institute of Technology), James Larkin(Trinity College Dublin)
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
July 12, 2008
Cited by 6
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2019|3.7k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k